NCT03693599View on ClinicalTrials.gov

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

PHASE4CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

September 15, 2019

Study Completion Date

September 30, 2019

Conditions
Post Partum Hemorrhage
Interventions
DRUG

carbetocin

single 100 µg IV dose of carbetocin diluted in 10 ml of Ringer's lactate solution (Pabal, Ferring Pharmaceuticals Ltd, West Drayton, UK).

DRUG

Syntometrine

one ampoule of syntometrine (Novartis, Basel, Switzerland), which consisted of 5 IU of oxytocin and 500 microgram of ergometrine diluted in 10 ml of Ringer's lactate solution and was administered intravenously over 2 minutes

Trial Locations (1)

11231

faculty of medicine Cairo university, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT03693599 - Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean | Biotech Hunter | Biotech Hunter